Metraipolis › archive › dc_7fff0984747e
Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles — Europe PMC PMID:42394794
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42394794
- DOI
- 10.1039/d6sc03923e
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T12:12:30.110Z
- SHA-256 of the archived text
e29e0d7237d731842e58684ef2b5cbadcb1073440c95706fb0a73d91efd48848- Stable URL of this page
https://metraipolis.com/documento/dc_7fff0984747e
How to cite
Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles — Europe PMC PMID:42394794 — Europe PMC (en), https://europepmc.org/article/MED/42394794 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fff0984747e (Metraipolis archive dc_7fff0984747e, sha256 e29e0d7237d731842e58684ef2b5cbadcb1073440c95706fb0a73d91efd48848)
BibTeX
@misc{dc7fff0984747e,
title = {Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles — Europe PMC PMID:42394794},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42394794},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fff0984747e; sha256 e29e0d7237d731842e58684ef2b5cbadcb1073440c95706fb0a73d91efd48848},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42394794. Agents can read the archived copy with the MCP tool read_document.